News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
David Planchard: Take home messages by Fabrice Barlesi on oncogenic treatment of localised NSCLC in 2025
Fabrice Barlesi/ilcnconference.com
Mar 26, 2025, 14:18

David Planchard: Take home messages by Fabrice Barlesi on oncogenic treatment of localised NSCLC in 2025

David Planchard, Thoracic Pathologist Committee at Gustave Roussy, shared a post on X:

“Clear messages and questions …from Fabrice Barlesi on oncogenic treatment of localised NSCLC in 2025.”

David Planchard: Take home messages by Fabrice Barlesi on oncogenic treatment of localised NSCLC in 2025

cancer David Planchard ELCC25 Fabrice Barlesi fight against cancer Global fight against cancer Gustave Roussy NSCLC OncoDaily oncogenic treatment Oncology
Special Coverage
Blog
Aug 5, 2025, 20:19
Niranjala Siriwardena: Australia Still Has No Workplace Cancer Survivorship Policy
Blog
Aug 5, 2025, 20:02
Voice of the Families: Mumbere’s Journey with Burkitt Lymphoma - CANCaRe Africa
Science
Aug 5, 2025, 19:50
Nicola Fusco: How Reliable Is ESR1 Mutation Testing in Liquid Biopsy for ER+/HER2- mBC?
Science
Aug 5, 2025, 19:24
Miguel Bronchud: Underestimation of Risk by Biopsies Alone Could Lead to Undertreatment in Prostate Cancer
Blog
Aug 5, 2025, 19:11
Miriam Mutebi: What Legacy Truly Means for African Leadership in Cancer Care
Insight
Aug 5, 2025, 18:55
Svetlana Nikic: Women Leading the Next Era of Cancer Care
Blog
Aug 5, 2025, 18:40
Upcoming Grand Rounds on the Future of Artificial Intelligence in Oncology - IOWG
Blog
Aug 5, 2025, 18:30
It’s Time to Move from Awareness to Action - ELPA
Blog
Aug 5, 2025, 18:18
Manoj Reddy: IOWG Grand Rounds Return after A Summer Break
Blog
Aug 5, 2025, 18:04
Why Focus on Alcohol-Related Liver Cancer? - GENIAL-Horizon Europe
Immune Oncology
Aug 5, 2025, 17:52
Top GU Immunotherapy Trials to Watch at ESMO 2025
Drugs
Aug 5, 2025, 17:18
Sakditad Saowapa: A Promising Targeted Option for Leptomeningeal Metastases from Solid Tumors